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Aim. To evaluate the agreement between different methods in detection of glaucomatous visual field progression using two
classification-based methods and four statistical approaches based on trend analysis. Methods. )is is a retrospective and
longitudinal study. Twenty Caucasian patients (mean age 73.8± 13.43 years) with open-angle glaucoma were recruited in the
study. Each visual field was assessed by Humphrey Field Analyzer, program SITA standard 30-2 or 24-2 (Carl Zeiss Meditec, Inc.,
Dublin, CA). Full threshold strategy was also accepted for baseline tests. Progression was analyzed by using Hodapp–
Parrish–Anderson classification and the Advanced Glaucoma Intervention Study visual field defect score. For the statistical
analysis, linear regression (r2) was calculated for mean deviation (MD), pattern standard deviation (PSD), and visual field index
(VFI), and when it was significant, each series of visual field was considered progressive. We also used Progressor to look for a
significant progression of each visual field series. )e agreement between methods, based on statistical analysis and classification,
was evaluated using a weighted kappa statistic. Results. )irty-eight visual field series were analyzed.)emean follow-up time was
6.2± 1.53 years (mean± standard deviation). At baseline, the mean MDwas −7.34± 7.18 dB; at the end of the follow-up, the mean
MD was −9.25± 8.65 dB; this difference was statistically significant (p< 0.001). )e agreement to detect progression was fair
between all methods based on statistical analysis and classification except for PSD r2. A substantial agreement (κ� 0.698± 0.126)
was found between MD r2 and VFI r2. With the use of all the statistical analysis, there was a better time-saving. Conclusions. )e
best agreement to detect progression was found between MD r2 and VFI r2. VFI r2 showed the best agreement with all the other
methods. GPA2 can help ophthalmologists to detect glaucoma progression and to help in treatment decisions. PSD r2 was the
worse method to detect progression.
1. Introduction
Glaucoma is a chronic disease characterized by an optic
neuropathy with irreversible damage to the optic nerve head
(ONH) and visual field (VF). From population studies, we
know that increased intraocular pressure is associated with
increased prevalence [1, 2] and incidence [3] of glaucoma.
With increasing life expectancy, it is fundamental to slow
down its progression to avoid visual disability and blindness.
Unfortunately, often times, the disease progresses despite
treatment; for this reason, it is important to monitor changes
and in particularly rates of change. )ese changes may be
observed by analyzing the ONH and the VF [4]. It is not easy
to recognize VF changes due to test variability [5–7], even if
field series are evaluated by experienced observers. Many
algorithms are able to distinguish between fluctuation of
sensitivity and progression, but no single one has been
identified as being superior to the other [8–10].
)ere are many approaches for detecting and quanti-
fying clinical progression [11]. Most often, progression is
based on the comparison of serial visual field printouts by
expert clinicians. However, this is often insufficient to
reliably determine progression; for this reason, classifica-
tion and statistical approaches exist. Classification systems
such as Hodapp–Parrish–Anderson [12] classification and
the Advanced Glaucoma Intervention Study [8] (AGIS)
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systematically score research protocols evaluating both
changes in depth and location (cluster analysis). )ese
methods are time-consuming but less subjective. )e
statistical methods are based on event and trend analysis.
While the event analysis looks for the subjective identifi-
cation of a confirmed event of change in a visual field series
compared to a baseline exam, the trend analysis uses linear
regression of the VF indices or of the sensitivity of the
tested points to detect glaucoma progression over time.
)e purpose of this study was to examine the level of
agreement between classification systems (Hodapp et al.
[12], AGIS [8]) and trend statistical methods (linear re-
gression of MD and PSD, Humphrey Guided Progression
Analysis (GPA) 2, and Progressor) in assessing VF
progression.
2. Patients and Methods
)is was a retrospective and longitudinal study with at least
5 years of follow-up (F/U). We followed in part the methods
of Iester et al. [4]. )e study, made in agreement with the
tenets of the Declaration of Helsinki, included 20 Caucasian
patients (mean age 73.8± 13.43 years) with primary open-
angle glaucoma recruited from the MI’s Glaucoma Clinic.
Visual fields were assessed by Humphrey Field Analyzer 750
II, (HFA, Carl Zeiss Meditec, Dublin, California, USA),
using the 30-2 or 24-2 SITA standard (Swedish interactive
thresholding algorithm) test. )e first 3 fields in each series
were excluded to minimize learning effects: the forth and
fifth full threshold or SITA Standard exams were used as
baseline. Full threshold strategy was also accepted only for
baseline tests. Patients were classified as having primary
open-angle glaucoma when they had a typical abnormal
ONH and/or a typical glaucomatous VF, open angle at
gonioscopy, IOP>21mm·Hg before treatment, and no
clinically apparent secondary cause for their glaucoma [13].
)e abnormal ONH classification [14] was based on the
presence of an optic rim notch or of diffuse/generalized loss
of optic rim tissue, vertical cup/disc diameter ratio asym-
metry unexplained by differences in optic disc size, or disc
hemorrhage. A glaucomatous VF defect [14] was defined as
three adjacent points depressed by 5 dB, with one of the
points depressed by at least 10 dB and two adjacent points
depressed by 10 dB, or a 10 dB difference across the nasal
horizontal meridian in two adjacent points. None of the
points could be edge points unless immediately above or
below the nasal horizontal meridian. In addition, visual field
testing was considered reliable only when false-negative
responses and fixation losses were less than 20%; unreli-
able VFs were not included in the analyses. Mean deviation
(MD) and pattern standard deviation (PSD) were considered
in the study to describe the included patients. Included
patients presented with a typical glaucomatous visual field
(baseline MD>3). Exclusion criteria were concomitant oc-
ular disease (for example, cataract), previous ocular surgery,
systemic disease or medication known to affect the VF,
refractive error exceeding 8D spherical equivalent or 3D of
astigmatism, and visual acuity< 20/50 at baseline or during
the F/U.
Progression was analyzed by using classification systems
and statistical analysis.
2.1. Hodapp–Parrish–Anderson Classification. )is classifi-
cation is based on two criteria. )e first criterion is the
overall extent of damage, which is calculated by using both
the MD value and the number of defective points in the
Humphrey Statpac 2 pattern deviation probability map of
the full threshold test. )e second criterion is based on the
defect proximity to the fixation point. )is system divides
early, moderate, and severe glaucomatous visual defects [13]
and recognizes the progression of visual field glaucoma
damage if a new defect in a previously normal area or a
decrease of sensitivity of a previously defect or a previously
defect that became larger or a general depression of visual
field sensitivity appears [12].
2.2. Advanced Glaucoma Intervention Study Scoring System.
It is a quantitative method used to assess test reliability and
to measure visual field defect severity using the Humphrey
threshold test. )e AGIS visual field defect score is based on
both the number and depth of adjacent depressed test lo-
cations in the nasal area, upper hemifield, and lower
hemifield.)is score is obtained from the total deviation plot
of the Statpac 2 single field analysis. A point is considered to
be defective when a minimum amount of sensitivity de-
pression is reached. Scores for each hemifield and for the
nasal area are summed. )e maximum possible score is 20
(two for the nasal field and nine for each hemifield). Pro-
gression is defined as an increase in score by 4 or more in
three consecutive follow-up fields [15].
2.3. Guided Progression Analysis 2 (GPA2). )e visual field
index (VFI) [16] is the trend analysis algorithm included in
the GPA2.)eVFI is a global parameter adjusted for age and
expressed in percentage (a perimetrically normal field is set
at 100% and a perimetrically blind one at 0%). To decrease
the influence of cataracts, the pattern deviation probability
map is used to identify test points with normal sensitivity
(considered normal and scored 100%), those showing rel-
ative loss (these are scored as a function of total deviation
and age-corrected normal threshold) and those showing no
sensitivity (scored 0%). )e VFI implements a weighting
procedure that assigns more importance to central points
than to peripheral points (considering 5 concentric rings of
increasing eccentricity in the visual field plot). A significant
trend was considered when the change in the VFI slope was
considered as statistically significant (p< 0.05) by GPA2. A
minimum of five exams over 3 years must be included in
GPA2 for the linear regression results to be presented. )e
length of projection is equal to the number of years of GPA2
data that is available, up to a maximum projection time of
5 years.
2.4. Progressor. It performs a point-by-point linear re-
gression analysis of sensitivity on time for the whole visual
field series. )e program produces a cumulative graphical
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output of each test location over time, using bar graphs. )e
height of the bar graphs above or below a horizontal line
represents the sensitivity of the testing location above or
below 30 dB, respectively, allowing visual comparison of
each point over time by the height of the subsequent bars.
Significant rate of changes is shown through color coding.
Pointwise linear regression analysis requires at least two
fields to generate a slope and a minimum of five fields to be
clinically useful. )e pointwise linear model has been
demonstrated to provide a valid framework for detecting
and forecasting glaucomatous loss [10]. In this study, the
level of statistical significance we used was p< 0.05, and the
rate of decibel loss we considered clinically significant was
>1 dB/year.
2.5. Mean Deviation (MD). It gives an overall value of the
total amount of visual field loss, with normal values typically
within 0 dB to −2 dB.
2.6. Pattern Standard Deviation (PSD). It measures irregu-
larity by summing the absolute value of the difference be-
tween the threshold value for each point and the average
visual field sensitivity at each point.
2.7. Statistical Analysis. For the statistical analysis, linear
regression (r2) was obtained from GPA2 (VFI) and Pro-
gressor, and r2 was calculated for MD and PSD. When
significant (p< 0.05), each VF series was considered
progressive.
)e agreement between methods, based on statistical
analysis and classification, was evaluated using a weighted
kappa statistic. )e κ statistic interpretation was as follows:
κ< 0, no agreement; κ� 0.0 to 0.19, poor; κ� 0.20 to 0.39,
fair; κ� 0.40 to 0.59, moderate; κ� 0.60 to 0.79, substantial;
and κ� 0.80 to 1.0, almost perfect agreement.
Time to decide if the VF series were getting worse was
calculated for each method.
3. Results
A total number of 303 visual fields divided into 38 VF series
of 20 patients were analyzed. Visual field tests were not
possible to perform in two eyes for the low visual acuity.
When possible, in the study, both eyes’ visual fields were
analyzed for patients, and the data were analyzed in-
dependently in a masked way without knowing the other eye
status.
)e mean follow-up time was 6.2± 1.53 years (mean ±
standard deviation). At baseline, the mean MD was −7.34
± 7.18 dB and the mean PSD was 5.67± 4.09 dB. At the end
of the follow-up, the mean MD was −9.25 ± 8.65 dB and the
mean PSD was 6.92 ± 4.67 dB. )e difference in perimetric
indices at baseline compared to those at end of follow-up
were statistically significant (Student’s t-test p< 0.05 and
p< 0.001, respectively, for MD and PSD).
Among the 38 VF series, 21 were considered as pro-
gressing using the Hodapp classification, 11 using the AGIS
scoring system, 13 withMD r2, 5 with PSD r2, 12 with VFI r2,
and 13 with Progressor. )e agreement in detecting pro-
gression was ≥ κ� fair for all methods except for PSD r2. A
substantial agreement (κ� 0.698± 0.126) was found between
MD r2 and VFI r2 (Table 1).
)emean time, expressed in minutes, needed to evaluate
the progression of VF series using the different methods is
summarized in Table 2. )e difference in time between
classification systems (Hodapp et al. [12], AGIS [8]) and
statistical methods (MD r2, PSD r2, VFI r2, and Progressor)
was statistically significant (Wilcoxon/Mann–Whitney test;
p< 0.001) with statistical methods being less time-
consuming.
4. Discussion
)e ability to detect the progression of visual field defects
remains one of the most challenging aspects of glaucoma
management.We found that, with the use of all the statistical
analyses, there was a greater time-saving which is very
important in the clinical practice [17]. In the event-based
statistical approach [18], the criterion for progression is
defined at the start of the study, and progression is con-
firmed when changes in VF have dipped below the preset
threshold. Information at baseline and that from the most
recent test is used to decide whether an eye has progressed or
not. Trend-based statistical methods [18] can be adopted to
improve progression rate measurement. )ese may be ap-
plied to the MD or VF sectors or at individual test locations
over time by linear regression analysis. )ese approaches
have been shown to be more sensitive in detecting pro-
gression than event-based analysis because all VF mea-
surements over the course of follow-up are taken into
consideration for the analysis; however, it is less accurate to
inform on the location of the damage.
In our study, the Hodapp et al. [12] classification
identified a greater number of progressive VF series com-
pared to the other methods. Hodapp et al. [12] classification
can be of great use in deciding when to start treatment once
glaucoma has been diagnosed and how aggressive therapy
should be, which is usually based on individual visual defect
severity. )e disadvantages include the fact that this three-
stage subdivision is too simplified and thus may make it
inappropriate for a fine categorization of visual field defects.
Moreover, it requires an accurate and time-consuming
analysis of every single visual field test result [19].
We can explain the poor agreement found between PSD
r2 and all the other methods as the PSD analyzes localized VF
defects. For this reason, it is not a good index when it is used
in the POAG follow-up. In fact while the PSD is able to
detect localized defects in early glaucoma, it is completely
insensitive to a decline in the global background visual field
level. PSD improves in the advanced stage of the disease;
thus, it is not useful in the follow-up when the damage is
advanced.
In our study, four eyes (11%) were identified as pro-
gressing by all statistical methods except PSD r2. )is low
concordance amongst different techniques has also been
reported by other investigators [20, 21].
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Up to now, many methods have been developed for
assessing glaucomatous VF progression, but there is no gold
standard method to detect progression. )ese methods that
quantify the rate of visual field progression seem, however,
to be the most appropriate for guiding treatment decisions
[22].
In our study, VFI r2 showed the best agreement with all
other methods, especially with MD r2. )e substantial
agreement found between VFI r2 and MD r2 is because both
are statistical reductions of the visual field sensitivity. VFI
was built considering MD values corrected with some co-
efficients calculated on the position of the tested points: the
paracentral points weigh more heavily in VFI than the more
peripheral ones [16]. Furthermore, VFI expresses the field as
a percentage of the “normal,” whereas MD in dB scale. )e
MD makes no such assumptions, so is physiologically more
robust. VFI is less affected by cataract and other media
changes than MD when using the pattern deviation prob-
ability map. It allows a quantification of the VF series by
comparing the defect depth with the normal age-adjusted
visual field. )is is done by taking into account the func-
tional damage related to eccentricity to correlate with
ganglion cell density. Moreover, it shows field status as a
percentage. )e latter easily allows, even for an ophthal-
mologist not specialized in glaucoma, to determine the rate
of VF progression, therefore allowing to set a target in-
traocular pressure and instilling an individualized treatment.
Furthermore, in the literature, different opinions about the
virtues of the VFI over a long-established compared to MD
are still present and on study [16, 23–26].
In conclusion, the best agreement to detect progression
was found between MD r2 and VFI r2, while PSD r2 was the
worse method to detect progression. VFI r2 showed the best
agreement with all the considered event analysis methods.
GPA2 could help ophthalmologists to detect glaucoma
progression and to help in treatment decisions because of the
VFI analysis and the event analysis graph which could help
to identify the VF area where the changes occur.
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